Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why This Speculative Investment Could Ruin Your Savings

In 2007, Americans saved a total of $57.4 billion. That same year, we spent $92.3 billion on legalized gambling.

That data, which comes from Christiansen Capital Advisors via Jason Zweig of The Wall Street Journal, says a lot.

Surprised by that imbalance?
We sure were. And while it's worrisome that we spend more on gambling than we save, it's even more troubling for another reason: We have an addiction to trying to get rich quick.

Gambling, after all, is about putting up a small amount of money in the hopes of winning a large amount of money. (We grant you that there's also an entertainment value to it.) It's a high-risk, high-reward game. Sounds a little bit like the ridiculous leverage major banks employed, both in the U.S. with Lehman Brothers, Bear Stearns, etc., and abroad, where banks including HSBC carried even more leverage than their U.S. counterparts.

The intersection of Wall and Main
As the savings stats suggest, Main Street Americans took on too much debt without enough cash in the bank back during those heady housing-boom years. We compounded the problem by taking unhealthy risks. We all know how that's turned out.

Thankfully, it was not all for naught. Groundbreaking new data has revealed that Americans have learned from the recent crisis and are changing their ways. We're getting smarter about saving, more conservative about the risks we take, and all in all setting up our country for a brighter financial future.

OK, that was some serious sarcasm
In reality, there is no groundbreaking new data. While U.S. savings rates are up (prompting some economists to worry about deflation), given the evidence, our guess is that that's a temporary phenomenon. Sketchy "get rich quick!" infomercials are back in full force, and speculative low-priced financial or biotech stocks such as Synovus Financial (NYSE: SNV  ) , Rexahn Pharmaceuticals (AMEX: RNN  ) , and Adventrx Pharmaceuticals (AMEX: ANX  ) are among the most heavily traded stocks in the market.

There's also a new scheme that individual investors are trying out: currency trading.

According to Aite Group, currency trading among retail investors is on the rise. Daily trading by these -- for lack of a better word -- amateurs was expected to rise to $125 billion per day in 2009, up from $100 billion per day last year and $10 billion per day in 2001. That's a lot.

But here's our advice when it comes to retail investors and currency trading: Unless you're a professional driver on a closed course, stay away.

Who listens to us?
Yet currency trading has big-time appeal to many small-time investors. As the Journal noted recently: "Investors are typically attracted to currency trading because of the vast leverage available -- as much as 500 to 1. That allows an investor to put up just a few hundred dollars of capital to make a bet of tens or hundreds of thousands of dollars."

While that is some serious upside, consider this: The vast majority of currency trades are made by hedge funds, large corporations, and central banks. In other words, your counterparty in a currency trade is likely to be someone who is -- and this is important -- vastly more qualified to make currency trades than you are. This prompted Gary Tilkin, chief executive of online firm GFT, to tell the Journal that trading currencies "is a business for speculators, not investors. It's more common to come in with $2,000 and lose than it is to turn that $2,000 into $25,000."

Your broker, however, will not tell you this. (Shocker.) The Journal notes that Citigroup (NYSE: C  ) now has products to entice retail investors.

The right idea, the wrong execution
Glibness aside, individual American investors are right to be worried about the future of the dollar. That's natural given that the U.S. national debt, stimulus spending, and inflation have made the future of the U.S. greenback a page-one headline in recent months.

Furthermore, we agree that the outlook for the dollar isn't so rosy. In fact, I (Tim) recently declared that the dollar is doomed and pointed investors to Philip Morris International -- my No. 1 dollar-protection stock.

While one stock is not enough to protect you and your savings from a decline in the dollar, currency trading is not the answer, either. What you need is a diversified portfolio with exposure to a basket of currencies, as well as to commodities that will hold value even as the dollar declines. That means stocks with 100% foreign exposure such as the aforementioned Philip Morris or (Nasdaq: CTRP  ) , stocks with vast commodity reserves like BHP Billiton (NYSE: BHP  ) , and careful, measured use of low-cost currency or commodity ETFs.

That's your huckleberry
A balanced approach like that will yield protection from a declining dollar without subjecting you to the massive risks of currency trading. Even better, it will help you make money slowly over time ... which, as history has shown us time and time (and time) again, is the only way to do so sustainably.

At Motley Fool Global Gains, we specialize in finding and vetting foreign stocks to help you achieve better global balance in what we'll guess is your dollar-denominated portfolio. While Philip Morris is a solid pick, there are many more currencies and countries you need exposure to. You can see all of our research and recommendations by being our guest at the service, free for 30 days. Click here to take us up on the offer.

Already a member of Global Gains? Log in at the top of this page.

This article was first published Oct. 12, 2009. It has been updated.

Brian Richards does not own shares of any companies mentioned. Tim Hanson owns shares of Philip Morris International, which is a Global Gains recommendation. Ctrip is a Motley Fool Hidden Gems pick. The Fool has a disclosure policy. It does not stockpile bullion.

Read/Post Comments (2) | Recommend This Article (16)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On February 23, 2010, at 6:12 AM, hjerk wrote:

    Did you inform Carl Ichan that he may be making a speculative investment that could ruin his savings?

    After seeing your comment about ANX, I made a buy when seeing Carl Ichan is one of their investors. In addition, I decided to use Investor's Business Daily for my stock references.

    My, you certainly have a comedy in print.

  • Report this Comment On February 24, 2010, at 9:29 PM, MrBlackHat wrote:


    I'm with hjerk. I just saw that too and made a purchase.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1115511, ~/Articles/ArticleHandler.aspx, 10/27/2016 10:56:10 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,177.18 -22.15 -0.12%
S&P 500 2,135.52 -3.91 -0.18%
NASD 5,234.46 -15.81 -0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/27/2016 10:40 AM
BHP $34.63 Down -0.62 -1.76%
BHP Billiton CAPS Rating: ***
C $50.02 Up +0.01 +0.02%
Citigroup CAPS Rating: ***
CTRP $45.79 Down -0.90 -1.93% Internat… CAPS Rating: ****
MSTX $0.08 Down +0.00 +0.00%
Mast Therapeutics CAPS Rating: ***
SNV $33.26 Up +0.13 +0.39%
Synovus Financial CAPS Rating: ****